RebotaREBOTA/Works Search tools, standards, templates… Ctrl K Rebota → Join free
Join free Log in Rebota business platform →
Rebota Tools · GST · HSN heading

HSN Code 3003: Medicaments (excluding goods of heading 3002

Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale. Chapter 30: Pharmaceutical products.

GST rate on HSN 3003
Nil to 18%

The rate depends on what the goods are: the notification gives a different rate to different descriptions. Match your goods to a description in the table below. In force on 7 Nov 2026.

Save to my items

GST rate entries for HSN 3003

Each row is an entry of a CBIC rate notification that names this heading, a code inside it or its whole chapter, in the notification's own words. Goods take the rate of the entry whose description fits them. GST is CGST plus SGST (or UTGST) in equal halves on a sale within a State, or IGST at the full rate on a sale between States.

GSTTariff entryDescription of goods, and source
5%2.5% + 2.5% 3003 Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale, including Ayurvedic, Unani, Siddha, homoeopathic or Bio-chemic systems medicaments Notification 9/2025-CT(R), Schedule I, S.No. 233
Entries for the whole of Chapter 30 (they apply where the description fits)
5%2.5% + 2.5% 2906 11 10, 30, 3301 Following goods from Natural Menthol namely:- a. Menthol and menthol crystals, b. Peppermint (Mentha Oil), c. Fractionated / de-terpenated mentha oil (DTMO) d. De-mentholised oil (DMO), e. Spearmint oil f. Mentha piperita oil Notification 9/2025-CT(R), Schedule I, S.No. 224
5%2.5% + 2.5% 30 Insulin, Cyclosporin, Desferrioxamine injection or deferiprone, Oral re-hydration salts Notification 9/2025-CT(R), Schedule I, S.No. 225
5%2.5% + 2.5% 30 or any Chapter All Drugs and medicines including their salts and esters and diagnostic test kits; formulations manufactured from bulk drugs [other than those specified at nil at S. No. 113 of notification No. 10/2025-Central Tax (Rate) dated 17th September, 2025] Notification 9/2025-CT(R), Schedule I, S.No. 226
5%2.5% + 2.5% 30 Diagnostic kits for detection of all types of hepatitis Notification 9/2025-CT(R), Schedule I, S.No. 227
5%2.5% + 2.5% 30 Medicaments (including veterinary medicaments) used in bio- chemic systems Notification 9/2025-CT(R), Schedule I, S.No. 228
5%2.5% + 2.5% 30 Medicaments (including those used in Ayurvedic, Unani, Siddha, Homeopathic or Bio-chemic systems), manufactured exclusively in accordance with the formulae described in the authoritative books specified in the First Schedule to the Drugs and Cosmetics Act, 1940 (23 of 1940) or Homeopathic Pharmacopoeia of India or the United States of America or the United Kingdom or the German Homeopathic Pharmacopoeia, as the case may be, and sold under the name as specified in such books or pharmacopoeia Notification 9/2025-CT(R), Schedule I, S.No. 229
18%9% + 9% 29061190, 30, 3301 Following goods made from other than natural menthol, namely:- a. Menthol and menthol crystals, b. Peppermint (Mentha Oil) c. Fractionated / de-terpenated mentha oil (DTMO) d. De-mentholised oil (DMO) e. Spearmint oil f. Mentha piperita oil Notification 9/2025-CT(R), Schedule II, S.No. 38
Nil 30 or any other Chapter Drugs or medicines listed in Annexure I
Annexure I: drugs or medicines (see S.No. 113 of the nil list) (37)
  • 1. Gene Therapy
  • 2. Agalsidase Beta
  • 3. Imiglucerase
  • 4. Eptacog alfa activated recombinant coagulation factor VIIa
  • 5. Onasemnogene abeparvovec
  • 6. Asciminib
  • 7. Mepolizumab
  • 8. Pegylated Liposomal Irinotecan
  • 9. Daratumumab
  • 10. Daratumumab subcutaneous
  • 11. Teclistamab
  • 12. Amivantamab
  • 13. Alectinib
  • 14. Risdiplam
  • 15. Obinutuzumab
  • 16. Polatuzumab vedotin
  • 17. Entrectinib
  • 18. Atezolizumab
  • 19. Spesolimab
  • 20. Velaglucerase Alpha
  • 21. Agalsidase Alfa
  • 22. Rurioctocog Alpha Pegol
  • 23. Idursulphatase
  • 24. Alglucosidase Alfa
  • 25. Laronidase
  • 26. Olipudase Alfa
  • 27. Tepotinib
  • 28. Avelumab
  • 29. Emicizumab
  • 30. Belumosudil
  • 31. Miglustat
  • 32. Velmanase Alfa
  • 33. Alirocumab
  • 34. Evolocumab
  • 35. Cystamine Bitartrate
  • 36. CI-Inhibitor injection
  • 37. Inclisiran
Notification 10/2025-CT(R), S.No. 113
Goods of this heading that fit none of the descriptions above
18%9% + 9%Any ChapterGoods which are not specified in Schedule I, III, IV, V, VI or VIINotification 9/2025-CT(R), Schedule II, S.No. 639 (the residual entry). A few entries cover goods of any chapter by description, such as puja samagri, rakhi or biomass briquettes; see the list on the finder.

HSN codes under 3003

Every 6- and 8-digit code of heading 3003 in the GSTN HSN master (34 codes), in GSTN's wording. Where a rate entry names a code more exactly than the heading, its rate is shown beside the code.

CodeDescription (GSTN master)Entry for this code
3003 10CONTAINING PENICILLINS OR DERIVATIVES THEREOF, WITH A PENICILLANIC ACID STRUCTURE, OR STREPTOMYCINS OR THEIR DERIVATIVES–
3003 10 00CONTAINING PENICILLINS OR DERIVATIVES THEREOF, WITH A PENICILLANIC ACID STRUCTURE, OR STREPTOMYCINS OR THEIR DERIVATIVES–Save
3003 20OTHER, CONTAINING ANTIBIOTICS–
3003 20 00OTHER, CONTAINING ANTIBIOTICS–Save
3003 31CONTAINING INSULIN–
3003 31 00CONTAINING INSULIN–Save
3003 39OTHER–
3003 39 00OTHER–Save
3003 40 00MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF TWO OR MORE CONSTITUENTS WHICH HAVE BEEN MIXED TOGETHER FOR THERAPEUTIC OR PROPHYLACTIC USES, NOT PUT UP IN MEASURED DOSES OR IN FORMS OR PACKINGS FOR RETAIL SALE CONTAINING ALKALOIDS OR DERIVATIVES THEREOF BUT NOT CONTAINING HORMONES OR OTHER PRODUCTS OF HEADING 2937 OR ANTIBIOTICS–Save
3003 41CONTAINING EPHEDRINE OR ITS SALTS–
3003 41 00Containing ephedrine or its salts–Save
3003 42CONTAINING PSEUDOEPHEDRINE (INN) OR ITS SALTS–
3003 42 00Containing pseudoephedrine (INN) or its salts–Save
3003 43CONTAINING NOREPHEDRINE OR ITS SALTS–
3003 43 00Containing norephedrine or its salts–Save
3003 49OTHER–
3003 49 00Other–Save
3003 60OTHER, CONTAINING ANTIMALARIAL ACTIVE PRINCIPLES DESCRIBED IN SUB-HEADING NOTE 2 TO THIS CHAPTER–
3003 60 00Other, containing antimalarial active principles described in Sub-heading Note 2 to this Chapter–Save
3003 90OTHER :–
3003 90 11OF AYURVEDIC SYSTEM–Save
3003 90 12OF UNANI SYSTEM–Save
3003 90 13OF SIDDHA SYSTEM–Save
3003 90 14OF HOMOEOPATHIC SYSTEM–Save
3003 90 15OF BIO-CHEMIC SYSTEM–Save
3003 90 21MENTHOL CRYSTALS–Save
3003 90 22MILK OF MAGNESIA–Save
3003 90 31BOVINE ALBUMIN AND DRUGS OF ANIMAL ORIGIN–Save
3003 90 32MERBROMINE NATIONAL FORMULARY XII (MERCUROCHROME)–Save
3003 90 33CALCIUM SENNOSIDE–Save
3003 90 34ANAESTHETIC AGENTS USED IN HUMAN OR VETERINARY MEDICINE OR SURGERY–Save
3003 90 35ALUMINIUM HYDROXIDE GEL–Save
3003 90 36KETAMINE–Save
3003 90 90OTHER–Save

Where HSN 3003 sits

Section VI (Chapters 28–38)Products of the chemical or allied industries
Chapter 30Pharmaceutical products
Heading 3003Medicaments (excluding goods of heading 3002

HSN 3003 on a GST invoice

Put the code in the HSN column of the tax invoice. Notification No. 78/2020-Central Tax sets the minimum digits by aggregate turnover in the previous financial year: 4 digits (3003) up to ₹5 crore, which may be left off invoices to unregistered buyers, and 6 digits (from the table above) above ₹5 crore. Where the table shows more than one rate, charge the rate of the entry whose description fits the goods sold.

The credit you miss is the credit nobody chased.Rebota reconciles GSTR-2B against your purchases and shows the mismatches supplier by supplier, with the amount at stake.
Reconcile your ITC →